Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2022 - 12 - 15 save search
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
Published: 2022-12-15 (Crawled : 21:00) - biospace.com/
TARS | $32.77 -2.79% -2.87% 320K
|
Health Technology
|
| O: -2.13%
H: 1.3%
C: 0.68%
tp-05 disease topline trial positive phase 2b
First Participant Dosed in Europe as Cognition Therapeutics Expand Phase 2 Alzheimer's Disease Clinical Trial of Oral CT1812SHINE Study Expanded from USA to Include sites in Spain, the Netherlands, and Czech Republic
Published: 2022-12-15 (Crawled : 21:00) - biospace.com/
CGTX | News | $2.0 0.0% 110K
|
|
| O: -0.75%
H: 2.26%
C: -1.13%
ct1812 europe disease alzheimer's trial therapeutics study
Global Rare Disease Drugs Market Report 2022-2027: Increasing Focus on Research Activities and Development of Novel Therapeutic Drugs to Facilitate Future Growth
Published: 2022-12-15 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.71%
H: 0.07%
C: -1.05%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.07%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.59%
H: 0.44%
C: -0.48%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
rare research global disease report growth market
Seelos Therapeutics Announces Data Demonstrating Downregulation of Alpha Synuclein in an In Vivo Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 in Parkinson's Disease
Published: 2022-12-15 (Crawled : 14:20) - biospace.com/
SEEL | $0.2971 -9.17% -10.1% 600K
|
Health Technology
|
| O: 3.1%
H: 0.0%
C: -18.05%
sls-004 disease parkinson's therapeutics therapy study
First Participant Dosed in Europe as Cognition Therapeutics Expand Phase 2 Alzheimer's Disease Clinical Trial of Oral CT1812
Published: 2022-12-15 (Crawled : 13:20) - globenewswire.com
CGTX | News | $2.0 0.0% 110K
|
|
| O: -0.75%
H: 2.26%
C: -1.13%
ct1812 europe disease alzheimer's trial therapeutics phase 2
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Published: 2022-12-15 (Crawled : 12:20) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.75%
H: 0.67%
C: -0.85%
disease cardiovascular
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
Published: 2022-12-15 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.78%
H: 0.92%
C: -0.18%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.83%
H: 0.66%
C: 0.3%
treatment disease collaboration
Addisons disease therapeutics market size to increase by USD 442 million: 41% growth to originate from North America - Technavio
Published: 2022-12-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.57%
H: 2.23%
C: 2.23%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.07%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.36%
H: 0.28%
C: -1.17%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.27%
H: 0.14%
C: -1.21%
TECH | $63.48 -0.33% -0.33% 980K
|
Health Technology
|
| O: -1.84%
H: 0.92%
C: -1.2%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.51%
H: 0.11%
C: -1.44%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.25%
H: 0.25%
C: -1.59%
america disease therapeutics growth market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.